Gang Lu is the founder of GluBio Therapeutics. GluBio Therapeutics has raised $90M in total funding. Latest round: Series A.
Gang Lu is a co-founder of GluBio Therapeutics, a biotechnology company established in March 2021. The company focuses on the discovery and development of novel targeted protein degradation (TPD) drugs for oncology, immunology, severe autoimmune disorders, and genetic conditions. GluBio Therapeutics has raised nearly $90 million in total funding to date.
Full founder directory · Investor directory · Company funding database · Fundraising library